晚期血清肿中CD30+ T细胞或不能诊断乳房假体相关间变性大细胞淋巴瘤
该病例报告对一例乳房重建22年后出现晚期血清肿的患者,采集血清肿液体和外周血,用24种单克隆抗体检测T细胞受体Vβ区域,流式细胞术设门CD3+和CD30+活化T淋巴细胞。血清肿细胞学显示活化T淋巴细胞谱,常规病理判定为非恶性;流式显示>23%的CD3+ T淋巴细胞属于表达TCRVβ13.2的扩增T细胞家族,多数Vβ13.2细胞表达CD30,外周血也检出较小扩增的CD30+ TCRVβ13.2 T细胞。结论认为该例CD30+活化T细胞扩增多克隆背景提示细菌超抗原可能参与致病,BIA-ALCL可能是CD30+ T细胞淋巴增殖性疾病的终末阶段。
要点
- 晚期血清肿中CD30+ T细胞扩增可见于非恶性病例,不能单独诊断BIA-ALCL。
- 该例血清肿和外周血均检出TCRVβ13.2扩增的CD30+活化T细胞,提示局部和全身免疫反应。
- 多克隆背景下的CD30+ T细胞扩增提示细菌超抗原可能参与,BIA-ALCL或为终末阶段。
核心结论
- 该例晚期血清肿中检出的CD30+活化T淋巴细胞扩增为非恶性,CD30在血清肿液体中并非ALCL所特有。
- 多克隆背景下的CD30+ T细胞扩增提示细菌超抗原可能作为致病因素,BIA-ALCL可能是CD30+ T细胞淋巴增殖性疾病的终末阶段。
研究设计与样本
- 病例报告,采集1例乳房重建22年后晚期血清肿患者的血清肿液体和外周血。
- 使用24种单克隆抗体检测T细胞受体Vβ区域,流式细胞术设门CD3+和CD30+活化T淋巴细胞,细胞离心涂片观察T淋巴细胞形态。
主要发现
- 血清肿液体细胞学显示类似传染性单核细胞增多症等免疫紊乱患者外周血中所见的活化T淋巴细胞谱,常规病理判定为非恶性。
- 流式细胞术显示>23%的CD3+ T淋巴细胞属于表达TCRVβ13.2的扩增T细胞家族,多数Vβ13.2细胞表达CD30。
- 外周血中检出较小扩增的CD30+ TCRVβ13.2 T淋巴细胞群体。
临床怎么用
- 对晚期血清肿中CD30+ T细胞增多需结合克隆性、形态学和临床背景综合判断,避免仅凭CD30诊断BIA-ALCL。
局限性
- 为单例病例报告,证据水平为5。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The objective was to analyze and discuss the implications of a nonmalignant CD30+ late seroma. Methods included collection of seroma fluid and peripheral blood from a patient with a late seroma 22 years after initial breast reconstruction. A panel of 24 monoclonal antibodies was used to detect T-cell receptor Vβ regions present on ~70% of normal human peripheral blood T lymphocytes. Flow cytometry gated on CD3+ and CD30+ activated T lymphocytes. Cytospins were used to inspect the morphology of the T lymphocytes. Results from the seroma fluid cytology revealed a spectrum of activated T lymphocytes as seen in the blood of patients with immune disorders such as infectious mononucleosis. Cells were judged to be nonmalignant by routine pathology. Flow cytometry revealed >23% of CD3+ T lymphocytes belonged to an expanded T-cell family expressing TCRVβ13.2. Most Vβ13.2 cells expressed T-cell activation antigen CD30 indicating that CD30 is not restricted to anaplastic large cell lymphoma (ALCL) in seroma fluids. A smaller expanded population of CD30+ T lymphocytes expressing TCRVβ 13.2 was detected in the blood. In conclusion, in this index case, an expanded population of CD30+ activated T lymphocytes was detected in seroma fluid surrounding a textured breast implant as well as in peripheral blood, consistent with a local and systemic immune response. The demonstration of an expanded CD30+ T-cell population in a polyclonal background suggests a possible role for bacterial superantigens as a pathogenic factor. These data further suggest that breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) may be the end stage of a CD30+ T-cell lymphoproliferative disorder. LEVEL OF EVIDENCE: 5.
引用
- Kadin ME, Morgan J, Xu H, et al. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017. PMID: 28402493. doi:10.1093/asj/sjw286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。